Another State Approves Pharmacy Access To Hormonal Contraceptives
US FDA Advisory Panel On OTC Birth Control Nears As Indiana Allows Pharmacist Prescription
Executive Summary
Indiana allows pharmacists, through a standing order from state health agency, to prescribe some hormonal contraceptives in pill or patch form. American College of Obstetricians and Gynecologists among recent supporters of OTC approval in comments to FDA.
You may also be interested in...
For First US OTC Birth Control Application, FDA Extends Time For Advisory Panel Discussion
After postponing planned November advisory committees’ meeting to have time to review more information it requested from sponsor HRA Pharma, FDA sets meeting for 9-10 May. Expanding meeting from one day to a day and a half should allow considering all views and questions about contraceptives.
OTC Birth Control Not Good For Women's Health, Natural Family Planning Group Says
SymptoPro Fertility Education focuses comments to FDA on potential side effects from Opill, suggesting its use could be linked to increased breast cancer risk, depression and ectopic pregnancy. Guttmacher Institute supports approval, saying “adolescents have most to gain.”
US OTC Birth Control NDA Could Debut ‘Additional Conditions for Nonprescription Use’ Labeling
HRA didn't have time to incorporate into its switch NDA instructions stated in proposed ACNU rule published in June, but the firm, which worked with Ibis Reproductive Health on proposal, had time to plumb a draft guidance FDA published in 2018 on novel switches.